Intera Atlas
Run match
Sites / CTI Clinical Research
Is this you?

Request access for CTI Clinical Research with your @ctifacts.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

CTI Clinical Research

Unclaimed profile

CRO · Covington, Kentucky (Cincinnati, Ohio operations) · ~1 primary Phase I unit (Cincinnati); global CRO with 29 countries, but primarily service-delivery focused, not site network sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 4Lift (cardio sample) 0.13Recruit soph 0.29
Quality Scorecard (1–100)
Overall63Recruit68Ops69Sponsor56Ther56

Performance (observed)

Historical trials
145
Completed
101
Terminated/Withdrawn
10
Completion rate
91%
Active now
33
Phase 2
48
Phase 3
78
Realized enrollment
411,828
First study year
2013
Years active
13
Match confidence
low
Enrollment velocity (inf)
31,679

Therapeutic

Areas
Full-service CRO: therapeutic expertise across range of services, early-phase to late-phase clinical development
Specialties
Rare diseases, transplantation, nephrology, immunology, oncology, personalized therapies
Breadth (conditions)
104
Languages
English + Spanish (detected)
States
OH, KY

Recruitment (web observed)

Patient database
Y (patient registry mentioned)
Recruitment pages
Yes
SEO
Y (news/events, consulting content)
Capability notes
CRO service provider; recruitment handled through sponsor/site networks, not primary recruitment platform

Relationships

Sponsors
Pfizer; Eli Lilly and Company; ModernaTX, Inc.; Apnimed; AbbVie; Allergan
CROs
ICON plc; Rho Federal Systems Division, Inc.; Veristat, Inc.
Partnerships
Crown Bioscience, BioAgilytix, H1
Owner / parent
Founded 1999; independent, founder-led
Acquisitions
Acquired Dynakin laboratory services (Europe/MEA)
Expansion
Multi-national; flagship lab Cincinnati; Dynakin acquisition EU/MEA
Recent hiring
Y (global expansion ongoing)

Capacity & people

Investigators
—
Coordinators
—
CEO
Timothy Schroeder (Founder)
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
Unknown

Tech & DCT

eSource
Yes
Builds tech
Unknown
DCT / decentralized
Y (global operations; 35+ countries)
Tech stack
Unknown
Recruiting visible
N

Notes

Weak Intera fit: CTI is a full-service CRO, not a multi-site SMO or site network. While founder-led (Timothy Schroeder, 1999) and large (~850 employees, $150M revenue), it is oriented toward sponsor/CRO business model, not site network portfolio. Limited Phase I facility presence vs comprehensive CRO services. Does not publicly advertise patient recruitment or consumer-facing recruitment services. Not positioned as site network operator with enrollment challenges. Better fit for CRO service relationships than patient recruitment platform. Global operations (29 countries) but structured as consulting/services firm, not site network with recruitment constraints. [Validated: 9 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.18Liftability 0.13Overall63

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.